Biomarkers for PANS in children
Part of Brain & nervous system, Mental health clinical trials.
This study looks for blood markers that could help diagnose and track pediatric acute-onset neuropsychiatric syndrome (PANS). If your child has PANS, participating could help improve understanding and treatment of this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a PANS diagnosis based on the 2010 NIH criteria.
- Your child cannot have certain rheumatologic or immunologic diseases.
- Your child must not have cancer or other severe medical conditions.
- Your child is not currently taking steroids or non-steroidal anti-inflammatory drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at physical, immune, and brain-related “markers” in children with PANS and compares them with healthy children. It may help doctors understand what is happening in PANS and how to recognize it more clearly early on.
This study looks at children who may have PANS or PANDAS, conditions that can cause sudden changes in behavior or mood after an infection. It aims to better understand these conditions and improve care.
This study looks at children who have had a first attack of nerve inflammation (like ADEM, vision loss, or spinal cord issues) to find markers in the blood that might show if it will come back. It tests blood and cells to better understand the immune response.
This study looks for biological “markers” that may help explain why asthma starts and how it changes over time in children. It may help your child’s doctors understand asthma better, especially for diagnosis or tracking.
This study collects samples like blood or tissue from children with pancreatitis to look for gene changes that might raise their risk. It helps doctors learn more about why some children get pancreas inflammation.
This study looks for biological markers in the blood or spinal fluid that might predict how well a new psychiatric treatment will work. If you have a psychiatric condition that hasn't improved with previous treatments, this research could help find better ways to match treatments to individuals in the future.
Hear when a new PANS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.